Deyaa Adib's most recent trade in FibroGen Inc was a trade of 22,123 Common Stock done at an average price of $1.2 . Disclosure was reported to the exchange on June 12, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
FibroGen Inc | Deyaa Adib | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.17 per share. | 12 Jun 2024 | 22,123 | 82,123 (0%) | 0% | 1.2 | 25,884 | Common Stock |